Mixing normal serum with serum from CLL patients restored C3b binding to bacterial surface, suggesting a defect in either the activation or activity of C3 in CLL serum, which likely accounts for the increased incidence of infections in these patients (56). This evidence concerns the gene C3 and B-cell chronic lymphocytic leukemia.